617 filings
Page 3 of 31
424B5
nb8 zelm403bvh0
7 Jul 23
Prospectus supplement for primary offering
5:25pm
424B5
0wo9ob6
7 Jul 23
Prospectus supplement for primary offering
5:20pm
8-K
l6vwr
6 Jul 23
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants
6:47pm
424B5
qy195phq
5 Jul 23
Prospectus supplement for primary offering
4:31pm
8-K
751wz3
5 Jul 23
Entry into a Material Definitive Agreement
4:17pm
8-K
6a81m lo7o
23 Jun 23
VBI Vaccines Announces Results of Annual General Meeting
4:05pm
8-K
t1sifgj8s xz2cdc1ty
15 Jun 23
VBI Vaccines Announces PreHevbri® is Now Available in the United Kingdom for the Prevention of Hepatitis B in Adults
8:00am
8-K
bq9mziwa ry5sg4
7 Jun 23
VBI Vaccines Announces Poster Presentation at EASL 2023
8:00am
8-K
674c8z0
15 May 23
VBI Vaccines Reports First Quarter 2023 Financial Results
8:00am
DEFA14A
czxgxwm531vn
2 May 23
Additional proxy soliciting materials
4:05pm
ARS
k8v8vk8hnv ekivj
1 May 23
Annual report to shareholders
4:05pm
DEFA14A
5u2y7b
1 May 23
Additional proxy soliciting materials
4:05pm
8-K
e9b983
28 Apr 23
Other Events
8:00am
8-K
4rj89h gm7o4q
25 Apr 23
VBI Vaccines Appoints Vaughn Himes to Board of Directors
8:00am
8-K
inkuizzm3wwd0bh7 p69
4 Apr 23
VBI Vaccines Announces Increased Focus on Hepatitis B, Organizational Changes, and Reverse Stock Split
8:00am
8-K
ws3y y68d6q8
13 Mar 23
VBI Vaccines Reports Full Year 2022 Financial Results
8:00am
8-K
ck0r96 gukt
28 Feb 23
Regulation FD Disclosure
1:01pm